person

Claudia T.

Country
Romania
Department
Hematology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 44 partner sites.

Specializations

Hematological Disorders

This investigator specializes in the study of hemophilia A and B, focusing on advancing treatment approaches for patients with bleeding disorders. Their research encompasses comprehensive evaluation of joint health outcomes in hemophilia patients.

  • Bleeding Disorders Management
  • Joint Health Assessment
  • Prophylactic Treatment Evaluation

The investigator utilizes advanced imaging techniques including ultrasound monitoring to assess treatment effectiveness in hemophilia patients.

Clinical Assessment

Expertise in conducting long-term clinical assessments, with particular focus on musculoskeletal outcomes in patients with inherited bleeding disorders. The investigator employs systematic monitoring approaches to evaluate treatment efficacy.

  • Longitudinal Patient Monitoring
  • Therapeutic Response Assessment
  • Clinical Outcomes Analysis

Their work involves detailed evaluation of prophylactic treatment regimens and their impact on patient health outcomes.

Therapeutic Innovation

The investigator's research focuses on evaluating novel therapeutic approaches for coagulation disorders, particularly in the context of extended half-life clotting factors. Their work contributes to understanding treatment effectiveness in real-world settings.

  • Coagulation Factor Therapy
  • Treatment Optimization
  • Patient Care Protocols

Emphasis is placed on studying prophylactic treatment strategies and their impact on long-term patient outcomes.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.